【英伟达支持的AI制药公司Iambic寻求美国上市】制药公司Iambic Therapeutics寻求通过首次公开募股融资至多1.594亿美元,英伟达是该公司股东之一。文件显示,公司计划以每股15至17美元的价格发行938万股。按照发行价区间上限及文件所列已发行在外股份计算,公司市值将约为8.058亿美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.